12.30
전일 마감가:
$12.69
열려 있는:
$12.3
하루 거래량:
1.73M
Relative Volume:
1.42
시가총액:
$1.19B
수익:
-
순이익/손실:
$-137.25M
주가수익비율:
-6.5079
EPS:
-1.89
순현금흐름:
$-121.97M
1주 성능:
-8.41%
1개월 성능:
+6.36%
6개월 성능:
+116.93%
1년 성능:
+29.75%
Oric Pharmaceuticals Inc Stock (ORIC) Company Profile
명칭
Oric Pharmaceuticals Inc
전화
(650) 388-5600
주소
240 E. GRAND AVE., SOUTH SAN FRANCISCO, CA
ORIC을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
ORIC
Oric Pharmaceuticals Inc
|
12.30 | 1.23B | 0 | -137.25M | -121.97M | -1.89 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Oric Pharmaceuticals Inc Stock (ORIC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-04 | 재개 | Guggenheim | Buy |
| 2025-07-08 | 개시 | Ladenburg Thalmann | Buy |
| 2024-10-31 | 개시 | Wells Fargo | Overweight |
| 2024-09-06 | 개시 | Stifel | Buy |
| 2024-02-23 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-09-22 | 개시 | Wedbush | Outperform |
| 2023-03-23 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2023-03-21 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2023-03-16 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2022-07-18 | 재개 | Oppenheimer | Perform |
| 2022-04-04 | 업그레이드 | Citigroup | Neutral → Buy |
| 2022-03-25 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2022-03-22 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-03-22 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2022-03-22 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2021-07-06 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-01-25 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2020-08-13 | 개시 | Robert W. Baird | Outperform |
| 2020-08-06 | 업그레이드 | Citigroup | Neutral → Buy |
| 2020-08-03 | 개시 | H.C. Wainwright | Buy |
| 2020-05-19 | 개시 | Citigroup | Neutral |
| 2020-05-19 | 개시 | Guggenheim | Buy |
| 2020-05-19 | 개시 | JP Morgan | Overweight |
| 2020-05-19 | 개시 | Jefferies | Buy |
모두보기
Oric Pharmaceuticals Inc 주식(ORIC)의 최신 뉴스
ORIC (NASDAQ: ORIC) at Guggenheim, Stifel, Jefferies; webcasts with 90-day replays - Stock Titan
Multi factor analysis applied to ORIC Pharmaceuticals Inc.July 2025 Movers & Real-Time Volume Analysis Alerts - newser.com
Why analysts recommend ORIC Pharmaceuticals Inc. (4TZ) stockPortfolio Performance Summary & Free Fast Gain Swing Trade Alerts - newser.com
What dividend safety score for ORIC Pharmaceuticals Inc. stockWeekly Trend Summary & Safe Capital Investment Plans - newser.com
Is this a good reentry point in ORIC Pharmaceuticals Inc.2025 Year in Review & Real-Time Buy Zone Alerts - newser.com
ORIC Pharmaceuticals Inc. stock chart pattern explainedRecession Risk & Real-Time Market Trend Scan - newser.com
Published on: 2025-11-04 01:17:21 - newser.com
Is ORIC Pharmaceuticals Inc. (4TZ) stock positioned for secular growthWeekly Gains Report & Expert Approved Trade Ideas - newser.com
Sector ETF performance correlation with ORIC Pharmaceuticals Inc.Weekly Market Report & Precise Entry and Exit Recommendations - newser.com
Sentiment analysis tools applied to ORIC Pharmaceuticals Inc.July 2025 Chart Watch & Weekly Watchlist for Hot Stocks - newser.com
Will ORIC Pharmaceuticals Inc. stock maintain momentum in 2025Weekly Market Outlook & Accurate Technical Buy Alerts - newser.com
Why ORIC Pharmaceuticals Inc. (4TZ) stock attracts HNW investorsGap Up & High Accuracy Investment Entry Signals - newser.com
Has ORIC Pharmaceuticals Inc. found a price floor2025 Market WrapUp & Risk Controlled Daily Plans - newser.com
Why ORIC Pharmaceuticals Inc. (4TZ) stock benefits from AI revolutionRisk Management & Technical Pattern Alert System - newser.com
AlphaQuest LLC Lowers Holdings in Oric Pharmaceuticals, Inc. $ORIC - MarketBeat
Can you recover from losses in ORIC Pharmaceuticals Inc.2025 Buyback Activity & Reliable Entry Point Alerts - newser.com
What to expect from ORIC Pharmaceuticals Inc. in the next 30 daysWeekly Volume Report & Daily Profit Focused Screening - newser.com
Is ORIC Pharmaceuticals Inc. stock attractive after correctionJuly 2025 Levels & Real-Time Stock Entry Alerts - newser.com
Published on: 2025-11-02 03:17:27 - newser.com
Relative strength of ORIC Pharmaceuticals Inc. in sector analysisJuly 2025 Drop Watch & Long-Term Safe Return Strategies - newser.com
How to read the order book for ORIC Pharmaceuticals Inc.2025 Earnings Surprises & Verified Technical Trade Signals - newser.com
D pipelineBull Run & Technical Confirmation Trade Alerts - newser.com
Why ORIC Pharmaceuticals Inc. (4TZ) stock stays on top picksBond Market & AI Forecasted Entry and Exit Points - newser.com
What technical models suggest about ORIC Pharmaceuticals Inc.’s comebackDividend Hike & AI Forecast for Swing Trade Picks - newser.com
Will ORIC Pharmaceuticals Inc. stock split again soonJuly 2025 PostEarnings & Risk Managed Investment Entry Signals - newser.com
Oric Pharmaceuticals Inc (ORIC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Oric Pharmaceuticals Inc 주식 (ORIC) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Piscitelli Dominic | Chief Financial Officer |
Oct 06 '25 |
Sale |
14.52 |
11,000 |
159,719 |
48,317 |
| Chacko Jacob | PRESIDENT AND CEO |
Oct 06 '25 |
Sale |
12.32 |
37,461 |
461,520 |
531,419 |
자본화:
|
볼륨(24시간):